Related content

Self-management of Oral Anticoagulant Therapy for Mechanical Heart Valve Patients

By Christensen Thomas D.   Attermann Jørn   Pilegaard Hans K.   Andersen Niels T.   Maegaard Marianne   Hasenkam J. Michael  

Scandinavian Cardiovascular Journal, Vol. 35, Iss. 2, 2001-03 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite

Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas

By Vallette Sophie   Serri Karim   Rivera Juan   Santagata Patricia   Delorme Sophie   Garfield Natasha   Kahtani Nora   Beauregard Hugues   Aris-Jilwan Nahla   Houde Ghislaine   Serri Omar  

Pituitary, Vol. 12, Iss. 3, 2009-09 ,pp. : 153-157

Springer Publishing Company

Access to resources Recommend Favorite

Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease

By Boudes Audrey   Lavoute Cécile   Avierinos Jean-François   Le Dolley Yvan   Villacampa Chloe   Salem Adrien   Loundou Anderson Dieudonné   Michel Nicolas   Renard Sébastien   Habib Gilbert  

European Journal of Echocardiography, Vol. 12, Iss. 9, 2011-09 ,pp. : 688-695

Oxford University Press

Access to resources Recommend Favorite

Point-of-care testing for assessment of adequacy of oral antiplatelet therapy in patients with cardiovascular disease

By Sobieraj-Teague Magdalena   Eikelboom John W  

Future Cardiology, Vol. 6, Iss. 3, 2010-05 ,pp. : 289-299

Future Medicine

Access to resources Recommend Favorite

Hormones and cardiovascular diseases: oral contraceptives and hormonal replacement therapy: differential effects on coronary heart disease, deep venous thrombosis and stroke

By ESHRE Capri Workshop Group The  

Human Reproduction, Vol. 13, Iss. 8, 1998-08 ,pp. : 2325-2333

Oxford University Press

Access to resources Recommend Favorite